FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that the first participant has been enrolled in the BLOOM Phase 2 ...

Hutchmed (China) Limited (Hutchmed), an innovative, commercial-stage, biopharmaceutical company, announced the results from the FRUSICA-2 registration clinical trial of the fruquintinib and sintilimab ...

Lithium Americas (NYSE:LAC) -1.8% post-market Monday after Bloomberg reported the U.S. Department of Energy is re-evaluating a $2.3 billion loan approved during the Biden administration for the ...

Welcome back to MoneyCall, The Athletic’s weekly sports business cheat sheet. (Want to receive this in your email every Wednesday morning? Subscribe here, it’s free.) Name-dropped today: Costco, Tom ...

LOS ANGELES, Aug. 12, 2025 /PRNewswire/ -- Abcentra LLC, a clinical-stage biopharmaceutical company pioneering targeted therapies for cardiovascular inflammation, today announced the successful dosing ...

Cosiporfin sodium (DVDMS)-mediated photodynamic therapy (PDT) versus treatment of physician’s choice (TPC) in patients (pts) with advanced esophageal cancer (aEC): A phase III, randomized, open-label, ...

SEATTLE, May 14, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer ...

Assessing 2-start fantasy baseball pitchers for Week 6, focusing on matchups against Minnesota and Toronto, with insights on Tanner Bibee and Luis Ortiz. Mark Carney Wins Canadian Election Dominated ...

NANTES, France – March 11, 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) and the GERCOR Group today announced that the primary endpoint has been reached in TEDOPaM (GERCOR ...

CAMBRIDGE, England--(BUSINESS WIRE)--Healx, an AI-enabled, clinical-stage biotech company dedicated to rare diseases, today announced the first patient has been dosed in INSPIRE-NF1, a Phase 2 trial ...

A tender process is open to the whole game, to join the revamped men’s Tier 2 competition (current Championship), launching in the 2025-26 season. Interested clubs, universities, colleges and others ...